The Value of Pharmaceutical Industry-Sponsored Patient Registries in Oncology Clinical Research

In May 2019, the US Food and Drug Administration (FDA) released the Framework for FDA’s Real-World Evidence (RWE) Program, a draft guidance to evaluate the potential use of real-world data in facilitating regulatory decisions. As a result, pharmaceutical companies and medical communities see patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Flick, E Dawn, Terebelo, Howard R, Fish, Susan, Kitali, Amani, Mahajan, Vrinda, Nifenecker, Melissa, Sullivan, Kristen, Thaler, Paul, Ussery, Sarah, Grinblatt, David L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Health Outcomes and Economics of Cancer Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400140/
https://www.ncbi.nlm.nih.gov/pubmed/37285045
http://dx.doi.org/10.1093/oncolo/oyad110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400140/
https://www.ncbi.nlm.nih.gov/pubmed/37285045
http://dx.doi.org/10.1093/oncolo/oyad110

Ejemplares similares